Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P S Schein

Showing results (201-210 of 218) with videos related to

Pageof 22
Sort By:
Clinical Toxicology|November 1, 1980
Will hemoperfusion be useful for cancer chemotherapeutic drug removal?J F Winchester, A Rahman, W J Tilstone, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1981
CEA (carcinoembryonic antigen): its role as a marker in the management of cancerD M Goldenberg, A M Neville, A C Carter, et al.
Cancer Treatment Reports|April 1, 1987
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health OrganizationJ D Ahlgren, F P Smith, E Cazap, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
The FAM regimen for gastric cancer: a progress reportP S Schein, J S Macdonald, P V Woolley, et al.
American Journal of Clinical Oncology|April 1, 1989
Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experienceJ Treat, S C Falchuk, P V Woolley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registryJ B Lesesne, N Rothschild, B Erickson, et al.
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
Cancer Treatment Reports|March 1, 1981
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lungR J Cambareri, F P Smith, J S Macdonald, et al.
Seminars in Oncology|August 1, 1996
Use of amifostine in bone marrow purgingP J Cagnoni, R B Jones, S I Bearman, et al.
Cancer|October 1, 1974
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)P S Schein, M J O'Connell, J Blom, et al.
Pageof 22

Showing results (201-210 of 218) with videos related to

Sort By:
Pageof 22
Clinical Toxicology|November 1, 1980
Will hemoperfusion be useful for cancer chemotherapeutic drug removal?J F Winchester, A Rahman, W J Tilstone, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1981
CEA (carcinoembryonic antigen): its role as a marker in the management of cancerD M Goldenberg, A M Neville, A C Carter, et al.
Cancer Treatment Reports|April 1, 1987
FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health OrganizationJ D Ahlgren, F P Smith, E Cazap, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1981
The FAM regimen for gastric cancer: a progress reportP S Schein, J S Macdonald, P V Woolley, et al.
American Journal of Clinical Oncology|April 1, 1989
Therapy of advanced gastric carcinoma. The Georgetown-Lombardi Cancer Center experienceJ Treat, S C Falchuk, P V Woolley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
Cancer-associated hemolytic-uremic syndrome: analysis of 85 cases from a national registryJ B Lesesne, N Rothschild, B Erickson, et al.
Cancer|October 1, 1982
Phase II studies of methyl glyoxal bis-guanylhydrazone (NSC 32946) in carcinoma of the colon and lungJ Y Killen, E P Mitchell, D F Hoth, et al.
Cancer Treatment Reports|March 1, 1981
CAMP (cyclophosphamide, doxorubicin, methotrexate, and procarbazine) for epidermoid and large cell anaplastic carcinoma of the lungR J Cambareri, F P Smith, J S Macdonald, et al.
Seminars in Oncology|August 1, 1996
Use of amifostine in bone marrow purgingP J Cagnoni, R B Jones, S I Bearman, et al.
Cancer|October 1, 1974
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)P S Schein, M J O'Connell, J Blom, et al.
Pageof 22